Vagotomy and subsequent development of diabetes - A nested case-control study.

Area of Science:

• Endocrinology
• Gastroenterology
• Metabolic Health

Background:

• Vagal nerve signaling influences gastric emptying and hormone secretion, playing a key role in metabolic homeostasis.
• Disruptions in vagal signaling are implicated in metabolic dysregulation.

Purpose of the Study:

• To test the hypothesis that vagotomy increases the risk of type 2 diabetes.
• To examine the association between vagotomy and the subsequent development of diabetes.

Main Methods:

• A nested case-control study utilizing the Danish National Patient Registry.
• Inclusion of individuals diagnosed with diabetes post-vagotomy (>12 months) and matched controls.
• Logistic regression analysis to assess the risk of diabetes development.

Main Results:

• Analysis included over 500,000 diabetes patients and 1.3 million controls.
• Vagotomy was performed on 2,772 individuals; 30,902 were diagnosed with diabetes.
• Vagotomy showed an unadjusted and adjusted odds ratio of 0.64 for developing diabetes (CI: 0.58-0.70).

Conclusions:

• Vagotomy is associated with a significantly reduced risk of developing type 2 diabetes.
• The findings suggest a protective effect of vagotomy against type 2 diabetes in patients with upper gastrointestinal disease.